scholarly article | Q13442814 |
P2093 | author name string | A M Sugar | |
L Z Goldani | |||
M Salibian | |||
P2860 | cites work | The clinical pharmacokinetics of itraconazole: an overview | Q34459180 |
Effect of cyclodextrin on the pharmacology of antifungal oral azoles | Q35826467 | ||
Interactions of amphotericin B and SCH 39304 in the treatment of experimental murine candidiasis: lack of antagonism of a polyene-azole combination | Q36754603 | ||
Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits | Q39851052 | ||
Antifungal activity of saperconazole (R 66 905) in vitro | Q69428150 | ||
In vitro antifungal activity of saperconazole (R 66905) against Candida and Torulopsis | Q69569191 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | candidiasis | Q273510 |
amphotericin B | Q412223 | ||
P304 | page(s) | 371-3 | |
P577 | publication date | 1994-02-01 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | Saperconazole therapy of murine disseminated candidiasis: efficacy and interactions with amphotericin B | |
P478 | volume | 38 |
Q33874835 | Agents for treatment of invasive fungal infections |
Q28379548 | Antifungal activity of 3'-deoxyadenosine (cordycepin) |
Q33693370 | Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model |
Q41740968 | Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development |
Q76381447 | Combination antifungal therapy |
Q60919818 | Combination of Posaconazole and Amphotericin B in the Treatment of Biofilms |
Q35112132 | Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B. |
Q35139011 | Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs |
Q46186301 | In vitro andin vivo antifungal activities of 6-[(N-4-bromophenyl) amino]-7-chloro-5,8-quinolinediones |
Q33803508 | Interaction between posaconazole and amphotericin B in concomitant treatment against Candida albicans in vivo |
Q90045315 | Synergistic antifungal interactions of amphotericin B with 4-(5-methyl-1,3,4-thiadiazole-2-yl) benzene-1,3-diol |
Q35117932 | Use of amphotericin B with azole antifungal drugs: what are we doing? |
Search more.